Search - tctmd.com

Displaying 961 - 980 of 1067

Sort: Relevancy | Date

Presentation TCT 2012

Stent Thrombosis: Mechanisms, Predictors, and Treatment

Presenter: George Dangas

October 23, 2012

Presentation TCT 2012

Stent Thrombosis Meta-analysis

Presenter: Tullio Palmerini

October 22, 2012

Presentation TCT 2012

DES Thrombosis: Acute Evaluation and Management for Short-term Success and Late Prevention

Presenter: Huay Cheem Tan

October 22, 2012

Presentation TCT 2012

A Detailed Analysis of Stent Thrombosis from the SYNTAX Trial (All Patients and Left Main vs. Multivessel Disease Cohorts): Frequency, Timing, Vessel, and Contribution to...

Presenter: Patrick Serruys

October 22, 2012

News Daily News

La Trombosis del Stent Causa de casi 1 de cada 10 STEMI

October 12, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Yael L. Maxwell

September 07, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

News Daily News

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

L.A. McKeown

August 23, 2012

News Daily News

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

L.A. McKeown

August 23, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

Meta-analysis: Bone Marrow Cell Transplantation Effective for Ischemic Heart Disease

June 29, 2012

Advertisement

Stent Thrombosis: Mechanisms, Predictors, and Treatment

Stent Thrombosis Meta-analysis

DES Thrombosis: Acute Evaluation and Management for Short-term Success and Late Prevention

A Detailed Analysis of Stent Thrombosis from the SYNTAX Trial (All Patients and Left Main vs. Multivessel Disease Cohorts): Frequency, Timing, Vessel, and Contribution to...

La Trombosis del Stent Causa de casi 1 de cada 10 STEMI

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

Indirect Comparisons Show Little Difference Among New Anticoagulants

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

Meta-analysis: Bone Marrow Cell Transplantation Effective for Ischemic Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content